Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China · Delayed Price · Currency is CNY 5.94
+0.10 (1.71%)
Jun 12, 2026, 3:04 PM CST
SHE:002550 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 7,424 | 9,823 | 7,749 | 7,525 | 8,012 | 6,181 | |
Market Cap Growth | -2.30% | 26.77% | 2.97% | -6.07% | 29.61% | 13.64% |
Enterprise Value | 6,143 | 8,782 | 7,071 | 7,054 | 7,540 | 5,582 |
Last Close Price | 5.94 | 7.67 | 5.95 | 5.52 | 5.76 | 4.34 |
PE Ratio | 22.95 | 24.63 | 21.76 | 41.38 | 24.77 | 34.14 |
Forward PE | - | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 |
PS Ratio | 5.02 | 6.25 | 5.08 | 4.15 | 3.48 | 3.30 |
PB Ratio | 2.60 | 3.55 | 3.08 | 3.04 | 3.29 | 2.92 |
P/TBV Ratio | 2.71 | 3.71 | 3.23 | 3.23 | 3.43 | 3.08 |
P/FCF Ratio | 28.39 | 44.70 | 18.27 | 17.38 | - | 468.80 |
P/OCF Ratio | 17.34 | 27.18 | 15.06 | 14.11 | - | 59.69 |
EV/Sales Ratio | 4.15 | 5.59 | 4.63 | 3.89 | 3.27 | 2.98 |
EV/EBITDA Ratio | 19.78 | 22.79 | 20.34 | 30.49 | 26.24 | 25.17 |
EV/EBIT Ratio | 24.99 | 27.39 | 25.06 | 43.50 | 33.88 | 36.63 |
EV/FCF Ratio | 23.49 | 39.96 | 16.68 | 16.29 | - | 423.36 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 |
Debt / EBITDA Ratio | 0.01 | 0.01 | 0.06 | 0.24 | 0.36 | 0.42 |
Debt / FCF Ratio | 0.01 | 0.02 | 0.05 | 0.13 | - | 7.10 |
Net Debt / Equity Ratio | -0.45 | -0.42 | -0.35 | -0.27 | -0.15 | -0.28 |
Net Debt / EBITDA Ratio | -4.12 | -3.00 | -2.55 | -2.84 | -1.30 | -2.67 |
Net Debt / FCF Ratio | -4.89 | -5.27 | -2.09 | -1.52 | 2.62 | -44.93 |
Asset Turnover | 0.48 | 0.53 | 0.55 | 0.65 | 0.87 | 0.76 |
Inventory Turnover | 1.55 | 1.67 | 1.35 | 1.84 | 3.03 | 2.92 |
Quick Ratio | 5.56 | 6.60 | 5.39 | 4.89 | 4.00 | 3.83 |
Current Ratio | 7.30 | 8.51 | 7.58 | 7.90 | 6.07 | 5.30 |
Return on Equity (ROE) | 10.86% | 14.13% | 13.35% | 7.28% | 14.06% | 8.91% |
Return on Assets (ROA) | 4.97% | 6.77% | 6.30% | 3.64% | 5.24% | 3.84% |
Return on Invested Capital (ROIC) | 12.67% | 16.41% | 13.77% | 7.34% | 11.02% | 9.41% |
Return on Capital Employed (ROCE) | 8.30% | 11.20% | 10.80% | 6.30% | 8.80% | 6.90% |
Earnings Yield | 4.35% | 4.06% | 4.59% | 2.42% | 4.04% | 2.93% |
FCF Yield | 3.52% | 2.24% | 5.47% | 5.75% | -1.78% | 0.21% |
Dividend Yield | 2.53% | 1.96% | 2.02% | 2.17% | 2.08% | 2.76% |
Payout Ratio | 46.38% | 37.72% | 42.56% | 87.31% | 47.98% | 83.67% |
Buyback Yield / Dilution | 1.72% | 1.99% | 2.11% | -0.41% | -7.16% | -0.58% |
Total Shareholder Return | 4.29% | 3.94% | 4.13% | 1.76% | -5.08% | 2.18% |